UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.805

Sortiert nach

Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients

Breast cancer research and treatment, 2017-06, Vol.163 (2), p.383-390

2017

Link zum Volltext

Verfügbarkeit prüfen

Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing

Breast cancer research and treatment, 2014-06, Vol.145 (3), p.707-714

2014

Link zum Volltext

Verfügbarkeit prüfen

Retrospective genetic testing (Traceback) in women with early-onset breast cancer after revised national guidelines: a clinical implementation study

Breast cancer research and treatment, 2024-06, Vol.205 (3), p.599-607

2024

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors: a comparison of patient-reported outcomes and quantitative sensory testing

Breast cancer research and treatment, 2019-12, Vol.178 (3), p.587-595

2019

Link zum Volltext

Verfügbarkeit prüfen

Genetic testing in women with early-onset breast cancer: a Traceback pilot study

Breast cancer research and treatment, 2021-11, Vol.190 (2), p.307-315

2021

Link zum Volltext

Verfügbarkeit prüfen

Genetic testing results in Slovenian male breast cancer cohort indicate the BRCA2 7806-2A > G founder variant could be associated with higher male breast cancer risk

Breast cancer research and treatment, 2021-08, Vol.188 (3), p.811-820

2021

Link zum Volltext

Verfügbarkeit prüfen

Hereditary cancer testing in a diverse sample across three breast imaging centers

Breast cancer research and treatment, 2024-01, Vol.203 (2), p.365-372

2024

Link zum Volltext

Verfügbarkeit prüfen

Access disparities and underutilization of germline genetic testing in Chilean breast cancer patients

Breast cancer research and treatment, 2023-06, Vol.199 (2), p.363-370

2023

Link zum Volltext

Verfügbarkeit prüfen

Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care

Breast cancer research and treatment, 2016-12, Vol.160 (3), p.393-410

2016

Link zum Volltext

Verfügbarkeit prüfen

Characterization of chemotherapy-induced peripheral neuropathy using patient-reported outcomes and quantitative sensory testing

Breast cancer research and treatment, 2021-04, Vol.186 (3), p.761-768

2021

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal adherence to breast cancer surveillance following cancer genetic testing in an integrated health care system

Breast cancer research and treatment, 2023-10, Vol.201 (3), p.461-470

2023

Link zum Volltext

Verfügbarkeit prüfen

Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43

Breast cancer research and treatment, 2013-11, Vol.142 (2), p.415-421

2013

Link zum Volltext

Verfügbarkeit prüfen

HBOC multi-gene panel testing: comparison of two sequencing centers

Breast cancer research and treatment, 2015-07, Vol.152 (1), p.129-136

2015

Link zum Volltext

Verfügbarkeit prüfen

Concordance analysis of paired cancer antigen (CA) 15-3 and 27.29 testing

Breast cancer research and treatment, 2018, Vol.167 (1), p.269-276

2018

Link zum Volltext

Verfügbarkeit prüfen

Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer

Breast cancer research and treatment, 2015-05, Vol.151 (1), p.169-176

2015

Link zum Volltext

Verfügbarkeit prüfen

BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer

Breast cancer research and treatment, 2018-02, Vol.168 (1), p.117-126

2018

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents

Breast cancer research and treatment, 2011-02, Vol.126 (1), p.215-220

2011

Link zum Volltext

Verfügbarkeit prüfen

Comparison of breast cancer HER-2 receptor testing with immunohistochemistry and in situ hybridization

Breast cancer research and treatment, 2023-02, Vol.198 (1), p.143-148

2023

Link zum Volltext

Verfügbarkeit prüfen

Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification

Breast cancer research and treatment, 2018-07, Vol.170 (2), p.321-328

2018

Link zum Volltext

Verfügbarkeit prüfen

Concordance with BRCA1/2 testing guidelines among women in The Health of Women (HOW) Study

Breast cancer research and treatment, 2019-02, Vol.173 (3), p.719-726

2019

Link zum Volltext

Verfügbarkeit prüfen

Patients’ perceptions of 70-gene signature testing: commonly changing the initial inclination to undergo or forego chemotherapy and reducing decisional conflict

Breast cancer research and treatment, 2020-07, Vol.182 (1), p.107-115

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer

Breast cancer research and treatment, 2017-08, Vol.164 (3), p.627-638

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of reactive changes on multigene testing: histopathologic analysis of low-grade breast cancers with high-risk 21-gene recurrence scores

Breast cancer research and treatment, 2024, Vol.203 (1), p.153-161

2024

Link zum Volltext

Verfügbarkeit prüfen

Impact of rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis on psychosocial functioning

Breast cancer research and treatment, 2022-02, Vol.191 (3), p.631-641

2022

Link zum Volltext

Verfügbarkeit prüfen

Association between physician characteristics and the use of 21-gene recurrence score genomic testing among Medicare beneficiaries with early-stage breast cancer, 2008–2011

Breast cancer research and treatment, 2018-07, Vol.170 (2), p.361-371

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.805

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

Zeitschrift / SerieBreast Cancer Research And Treatment

ThemaFemale

ThemaMedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.805)
Mit Volltextzugriff
(1.805)

Publikationsform

Artikel
(1.805)

Sprache

Englisch
(1.805)
Japanisch
(238)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

13 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ovid SocietyJournals and Single Titles
(1.805)
SpringerLink Journals - AutoHoldings
(1.805)
MEDLINE
(1.803)
IngentaConnect Journals
(125)

Neu hinzugefügt

... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients

Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing

Retrospective genetic testing (Traceback) in women with early-onset breast cancer after revised national guidelines: a clinical implementation study

Chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors: a comparison of patient-reported outcomes and quantitative sensory testing

Genetic testing in women with early-onset breast cancer: a Traceback pilot study

Genetic testing results in Slovenian male breast cancer cohort indicate the BRCA2 7806-2A > G founder variant could be associated with higher male breast cancer risk

Hereditary cancer testing in a diverse sample across three breast imaging centers

Access disparities and underutilization of germline genetic testing in Chilean breast cancer patients

Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care

Characterization of chemotherapy-induced peripheral neuropathy using patient-reported outcomes and quantitative sensory testing

Longitudinal adherence to breast cancer surveillance following cancer genetic testing in an integrated health care system

Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43

HBOC multi-gene panel testing: comparison of two sequencing centers

Concordance analysis of paired cancer antigen (CA) 15-3 and 27.29 testing

Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer

BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer

Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents

Comparison of breast cancer HER-2 receptor testing with immunohistochemistry and in situ hybridization

Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification

Concordance with BRCA1/2 testing guidelines among women in The Health of Women (HOW) Study

Patients’ perceptions of 70-gene signature testing: commonly changing the initial inclination to undergo or forego chemotherapy and reducing decisional conflict

Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer

Impact of reactive changes on multigene testing: histopathologic analysis of low-grade breast cancers with high-risk 21-gene recurrence scores

Impact of rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis on psychosocial functioning

Association between physician characteristics and the use of 21-gene recurrence score genomic testing among Medicare beneficiaries with early-stage breast cancer, 2008–2011

Aktive Filter

Suchergebnisse filtern